Scientific News Why Thermo Fisher Scientific Tmo Is The Best Stock To Buy In 2025 For Beginners

Is Thermo Fisher Scientific Inc Gaining or Losing Market Support?

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ... Read More

Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3

Parnassus Investments, an investment management company, released the “Parnassus Core Equity Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. Read More

Analysts see 12% upside to Thermo Fisher Scientific Inc. (TMO)

Thermo Fisher Scientific Inc. (NYSE:TMO) is among the 14 Best S&P 500 Stocks to Buy Now. As of the close of business on December 17, Wall Street analysts have a consensus Strong Buy rating on the ... Read More

Price Over Earnings Overview: Thermo Fisher Scientific

In the current market session, Thermo Fisher Scientific Inc. (NYSE: TMO) stock price is at $575.01, after a 0.04% drop. However, over the past month, the company's stock increased by 0.49%, and in the ... Read More

Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector?

With a market cap of $220 billion, Thermo Fisher Scientific Inc. (TMO) is a prominent Massachusetts-based biotechnology and life sciences company that provides a wide range of products and services ... Read More

Goldman Sachs Initiates Coverage of Thermo Fisher Scientific (TMO) with Buy Recommendation

Fintel reports that on December 9, 2025, Goldman Sachs initiated coverage of Thermo Fisher Scientific (NYSE:TMO) with a Buy recommendation. As of December 6, 2025, the average one-year price target ... Read More

Argus Research Maintains Thermo Fisher Scientific (TMO) Buy Recommendation

Fintel reports that on October 29, 2025, Argus Research maintained coverage of Thermo Fisher Scientific (NYSE:TMO) with a Buy recommendation. As of October 29, 2025, the average one-year price target ... Read More

Thermo Fisher Scientific: More Upside Likely As Headwinds Continue To Fade And Valuation Still Attractive

Thermo Fisher is well-positioned for continued revenue growth driven by easing pharma uncertainty, reshoring, and recovering clinical research trends. Margins should expand through operating leverage, ... Read More

Here’s Why Baron Health Care Fund Added Thermo Fisher Scientific (TMO) to Its Portfolio

Baron Funds, an investment management company, released its “Baron Health Care Fund” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The fund rose 5.39% (Institutional ... Read More